SHD1 Activators
SH2D1A Activators represent a diverse array of chemical entities that indirectly enhance the functional activity of SH2D1A through intricate and specific signaling pathways. The activation of protein kinase C (PKC) by compounds like Phorbol 12-myristate 13-acetate (PMA) can lead to the phosphorylation of proteins that interface with SH2D1A, thereby potentiating its role in cellular signaling. Similarly, Ionomycin, by elevating intracellular calcium levels, may enhance SH2D1A activity by influencing calcium-dependent signaling pathways which are pivotal in immunoreceptor signaling. Forskolin, through the upregulation of cAMP, indirectly stimulates SH2D1A activity via protein kinase A (PKA), which can phosphorylate target proteins in pathways where SH2D1A is a key player. Moreover, the engagement of Prostaglandin E2 (PGE2) with its receptors can lead to a cascade of events reinforcing SH2D1A-mediated signaling, particularly within T-cell receptor pathways.
Furthermore, the SH2D1A protein's activity is intricately modulated by a web of biochemical pathways influenced by the aforementioned chemicals. Brefeldin A, by disrupting Golgi apparatus function, may affect protein interactions and signaling pathways that indirectly augment the function of SH2D1A in immune cells. Okadaic acid, through the inhibition of protein phosphatases, could result in an elevated phosphorylation state within SH2D1A-associated pathways, indirectly magnifying its activity. Thapsigargin and Zaprinast operate by modulating intracellular calcium and cGMP levels, respectively, thus potentially enhancing SH2D1A signaling. Cyclosporin A, LY294002, SP600125, and U0126 each manipulate different aspects of cellular signaling-ranging from calcineurin inhibition to interference with PI3K, JNK, and MEK pathways-all of which can lead to an indirect upregulation of SH2D1A's role in immune system signaling, highlighting the complexity and interconnected nature of cellular activation mechanisms.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to an increase in cyclic AMP (cAMP) levels. Elevated cAMP activates protein kinase A (PKA), which can then phosphorylate and enhance the activity of SHD1 by altering its conformation or promoting its interaction with other signaling proteins. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) is a nonspecific inhibitor of phosphodiesterases, enzymes that degrade cAMP. By preventing cAMP degradation, IBMX indirectly maintains high levels of PKA activity, which could enhance SHD1 activity through phosphorylation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) is a diacylglycerol analog that activates protein kinase C (PKC). Activated PKC may phosphorylate SHD1 or related signaling molecules, leading to the enhanced activity of SHD1. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore, which increases intracellular calcium levels and activates calcium-dependent signaling pathways. This activation can lead to the phosphorylation and enhancement of SHD1 activity, if SHD1 is regulated by calcium signaling. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate (EGCG) is a polyphenol that can inhibit certain kinases. Inhibition of these kinases may alleviate negative regulatory constraints on SHD1, thus enhancing its functional activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid affects gene expression by activating nuclear receptors. If SHD1 activity is modulated by proteins that are transcriptionally regulated by retinoic acid, this compound could indirectly enhance SHD1 activity through such mechanisms. | ||||||
Sodium Fluoride | 7681-49-4 | sc-24988A sc-24988 sc-24988B | 5 g 100 g 500 g | $40.00 $46.00 $100.00 | 26 | |
Sodium fluoride is an inhibitor of phosphatases, enzymes that remove phosphate groups from proteins. Inhibition of phosphatases can lead to increased phosphorylation and potential enhancement of SHD1 activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a specific inhibitor of protein phosphatase 1 (PP1) and 2A (PP2A). By inhibiting these phosphatases, okadaic acid may indirectly increase the phosphorylation and activity of SHD1 if SHD1 is regulated by dephosphorylation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin inhibits protein synthesis at the level of peptide elongation. In certain contexts, this inhibition can lead to the activation of stress-activated protein kinases (SAPKs), which may enhance SHD1 activity if SHD1 is a substrate or is regulated by SAPKs. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable analog of cAMP that activates PKA. Activation of PKA can result in the phosphorylation and subsequent activation of SHD1, assuming SHD1 activity is modulated by PKA. | ||||||